| Drug Type Fusion protein | 
| Synonyms Fas/IL-2R agonists (Fascure Therapeutics) | 
| Target | 
| Action stimulants, agonists | 
| Mechanism FasR stimulants(Apoptosis-mediating surface antigen FAS stimulants), IL-2R agonists(Interleukin-2 receptor agonists) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePreclinical | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Graft Rejection | Preclinical | United States  | - | 






